Osteoporosis Research Today is a free monthly online journal that collates and summarizes the latest research about Osteoporosis, including details on symptoms, treatment, prevention, causes.

Volume 4 (2007), Issue 3 (March)

1. Glucocorticoid-induced osteoporosis in children: impact of the underlying disease.
   Pediatrics, 119: S166-74. [Abstract] [Full-text]
2. SERMs: meeting the promise of multifunctional medicines.
   J Natl Cancer Inst, 99(5): 350-6. [Abstract] [Full-text]
3. Gaps in treatment among users of osteoporosis medications: the dynamics of noncompliance.
   Am J Med, 120(3): 251-6. [Abstract] [Full-text]
4. A claims database analysis of persistence with alendronate therapy and fracture risk in post-menopausal women with osteoporosis.
   Curr Med Res Opin, 23(3): 585-94. [Abstract] [Full-text]
5. Clinician practices for the management of amenorrhea in the adolescent and young adult athlete.
   J Adolesc Health, 40(4): 362-5. [Abstract] [Full-text]
6. Randomized controlled trial of annual zoledronic acid to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer.
   J Clin Oncol, 25(9): 1038-42. [Abstract] [Full-text]
7. Fat mass and skeletal muscle mass in hip-fracture women: a cross-sectional study.
   Maturitas, 56(4): 404-10. [Abstract] [Full-text]
8. Relationship between adolescent amenorrhea and climacteric osteoporosis.
   Maturitas, 56(4): 368-74. [Abstract] [Full-text]
9. Body mass index and gynecological factors as determinants of bone mass in healthy Moroccan women.
   Maturitas, 56(4): 375-82. [Abstract] [Full-text]
10. Peripheral quantitative computed tomography (pQCT) is useful for monitoring bone mineral density of the patients who receive hormone replacement therapy.
    Maturitas, 56(4): 343-9. [Abstract] [Full-text]
11. Risedronate and ergocalciferol prevent hip fracture in elderly men with Parkinson disease.
    Neurology, 68(12): 911-5. [Abstract] [Full-text]
12. Steroid hormone receptor gene polymorphisms and osteoporosis: a pharmacogenomic review.
    Expert Opin Pharmacother, 8(5): 537-53. [Abstract] [Full-text]
13. Modulation of soy isoflavones bioavailability and subsequent effects on bone health in ovariectomized rats: the case for equol.
    Osteoporos Int, 18(5): 671-9. [Abstract] [Full-text]
14. Prediction of absolute risk of non-spinal fractures using clinical risk factors and heel quantitative ultrasound.
    Osteoporos Int, 18(5): 629-39. [Abstract] [Full-text]
15. Hospitalised osteoporotic vertebral fractures in Spain: analysis of the national hospital discharge registry.
    Osteoporos Int, 18(5): 649-57. [Abstract] [Full-text]
16. Influence of fall related factors and bone strength on fracture risk in the frail elderly.
    Osteoporos Int, 18(5): 603-10. [Abstract] [Full-text]
17. The association between non-melanoma skin cancer and osteoporotic fractures--a population-based record linkage study.
    Osteoporos Int, 18(5): 687-92. [Abstract] [Full-text]
18. The vertebral fracture cascade in osteoporosis: a review of aetiopathogenesis.
    Osteoporos Int, 18(5): 575-84. [Abstract] [Full-text]
19. Trends in hospital care for hip fractures.
    Osteoporos Int, 18(5): 585-91. [Abstract] [Full-text]

© 2004-2008 Osteoporosis Research Today. All Rights Reserved.